Gilead Oncology Sales Take Off As Veklury’s Come Down To Earth

Q2 Saw Cancer Drug Sales Up 71%

Gilead reported its second quarter 2022 sales • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business